Condition: Urinary Tract Infections · Sponsor: Wake Forest University Health Sciences
Recently more advanced techniques, including Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) are available to detect bacteria in urine based on bacterial genomes. Comparing to traditional culture, these techniques have more sensitivity and could potentially be of a great help in patients with Colony Count of less than 10,000 and more than zero.
This description comes directly from the study's public registry record.
Majid Mirzazadeh, MD · 336-716-4310 · mmirzaza@wakehealth.edu
Sachin N Vyas, MS, PhD · 336-713-4098 · sachin.vyas@advocatehealth.org
Always discuss trial participation with your own doctor first.
| Wake Forest Health Sciences | Winston-Salem, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05206500